关注
Li Xu
Li Xu
UCB Biosciences Inc
在 ucb.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice
L Xu, KH Park, L Zhao, J Xu, M El Refaey, Y Gao, H Zhu, J Ma, R Han
Molecular Therapy 24 (3), 564-569, 2016
2802016
In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice
M El Refaey, L Xu, Y Gao, BD Canan, TMA Adesanya, SC Warner, ...
Circulation research 121 (8), 923-929, 2017
1512017
The intracellular Ca2+ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy
X Cheng, X Zhang, Q Gao, M Ali Samie, M Azar, WL Tsang, L Dong, ...
Nature medicine 20 (10), 1187-1192, 2014
1302014
Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA
L Xu, L Zhao, Y Gao, J Xu, R Han
Nucleic acids research 45 (5), e28-e28, 2017
1102017
A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9
T Sui, YS Lau, D Liu, T Liu, L Xu, Y Gao, L Lai, Z Li, R Han
Disease models & mechanisms 11 (6), dmm032201, 2018
952018
Efficient precise in vivo base editing in adult dystrophic mice
L Xu, C Zhang, H Li, P Wang, Y Gao, NA Mokadam, J Ma, WD Arnold, ...
Nature communications 12 (1), 3719, 2021
912021
Life-long AAV-mediated CRISPR genome editing in dystrophic heart improves cardiomyopathy without causing serious lesions in mdx mice
L Xu, YS Lau, Y Gao, H Li, R Han
Molecular Therapy 27 (8), 1407-1414, 2019
512019
MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
H Li, PH Lin, P Gupta, X Li, SL Zhao, X Zhou, Z Li, S Wei, L Xu, R Han, ...
Molecular cancer 20, 1-15, 2021
492021
Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy
J Xu, M El Refaey, L Xu, L Zhao, Y Gao, K Floyd, T Karaze, PML Janssen, ...
Skeletal muscle 5, 1-14, 2015
492015
Automated muscle histopathology analysis using CellProfiler
YS Lau, L Xu, Y Gao, R Han
Skeletal muscle 8, 1-9, 2018
472018
Targeted myostatin gene editing in multiple mammalian species directed by a single pair of TALE nucleases
L Xu, P Zhao, A Mariano, R Han
Molecular Therapy-Nucleic Acids 2, 2013
462013
Dysferlin forms a dimer mediated by the C2 domains and the transmembrane domain in vitro and in living cells
L Xu, S Pallikkuth, Z Hou, GA Mignery, SL Robia, R Han
PloS one 6 (11), e27884, 2011
422011
BEAT: a Python program to quantify base editing from sanger sequencing
L Xu, Y Liu, R Han
The CRISPR journal 2 (4), 223-229, 2019
342019
Studies on preparation and photodynamic mechanism of chlorin P6-13, 15-N-(cyclohexyl) cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo
Y Yan, M Zheng, Z Chen, X Yu, X Yang, Z Ding, L Xu
Bioorganic & medicinal chemistry 18 (17), 6282-6291, 2010
322010
Anoctamin 6 regulates C2C12 myoblast proliferation
P Zhao, A Torcaso, A Mariano, L Xu, S Mohsin, L Zhao, R Han
PLoS One 9 (3), e92749, 2014
282014
BEON: a functional fluorescence reporter for quantification and enrichment of adenine base-editing activity
P Wang, L Xu, Y Gao, R Han
Molecular Therapy 28 (7), 1696-1705, 2020
222020
Highly efficient genome editing via 2A-coupled co-expression of two TALEN monomers
A Mariano, L Xu, R Han
BMC research notes 7, 1-5, 2014
152014
A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation‐prone Ano5 peptide
J Xu, L Xu, YS Lau, Y Gao, SA Moore, R Han
The Journal of Pathology: Clinical Research 4 (2), 135-145, 2018
102018
Equal force recovery in dysferlin‐deficient and wild‐type muscles following saponin exposure
P Zhao, L Xu, Y Ait-Mou, PP De Tombe, R Han
BioMed Research International 2011 (1), 235216, 2011
92011
BVES is a novel interactor of ANO5 and regulates myoblast differentiation
H Li, L Xu, Y Gao, Y Zuo, Z Yang, L Zhao, Z Chen, S Guo, R Han
Cell & Bioscience 11, 1-10, 2021
82021
系统目前无法执行此操作,请稍后再试。
文章 1–20